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HIGHLIGHTS
Derangement of autonomic nervous signaling is an important contributor to cardiac arrhythmogenesis.
Modulation of autonomic nervous signaling holds significant promise for the prevention and treatment of cardiac arrhythmias.
Further clinical investigation is necessary to establish the efficacy and safety of autonomic modulatory therapies in reducing cardiac arrhythmias.
SUMMARY
There is an increasing recognition of the importance of interactions between the heart and the autonomic nervous system in the pathophysiology of arrhythmias. These interactions play a role in both the initiation and maintenance of arrhythmias and are important in both atrial and ventricular arrhythmia. Given the importance of the autonomic nervous system in the pathophysiology of arrhythmias, there has been notable effort in the field to improve existing therapies and 
ANATOMY OF THE NEUROCARDIAC AXIS
The neurocardiac axis is composed of multiple intricate areas that provide an interface between the nervous system and the cardiovascular system ( Figure 1 ).
This neurocardiac anatomy has been elegantly detailed in a recent review (1) . A number of diverse brain structures contribute to efferent cardiac autonomic signaling, including the amygdala, insula, thalamus, and cerebellum (2) . In general, second-tosecond control of autonomic tone occurs at the level of the brainstem, whereas forebrain structures including the hypothalamus effect more prolonged or gradual shifts in autonomic tone (3) . problem that affects approximately 3% of the population (7) . As the population ages, the incidence and prevalence of AF are projected to increase even further (8) . In addition to being a leading cause of stroke, AF is associated with increased risks of heart failure (HF), myocardial infarction (MI), cognitive impairment, and death (9) .
The severity or persistence of AF has been associated with worse outcomes, including a higher risk of stroke (10) ; however, the role of AF burden (proportion of time spent in AF) in adverse outcomes remains incompletely understood (11) . Given both its prevalence and impact, AF is a significant public health concern, and reduction of AF and its attendant complications remains a priority for the cardiovascular community.
An increasing body of evidence suggests that activity of the ANS can contribute to the initiation and perpetuation of cardiac arrhythmias, including AF. In isolated atrial myocytes, parasympathetic input shortens the atrial effective refractory period (AERP) (12) and increases dispersion of refractoriness (13), whereas sympathetic input increases calcium transient currents and afterdepolarizations (4), synergistically promoting the onset of AF (14) . Similar responses to sympathetic stimulation are observed in pulmonary veins, a common site of ectopy that triggers AF (15) . Although both parasympathetic and sympathetic stimulation may individually promote AF (16, 17) , data suggest that combined parasympathetic and sympathetic (sympathovagal) discharges are especially potent initiators of AF (15, 18) due to the combined effects of shortened AERP and increased calcium transient currents, respectively. Changes in heart rate variability (HRV) before onset of AF (19, 20) are consistent with combined sympathovagal discharges. There are also data to suggest that AGP may influence focal sources or drivers of AF. For example, a study of 97 patients undergoing catheter ablation of AF has shown that the majority of patients had a focal source or rotor that overlapped with the anatomic location of an AGP (21) . Because AGPs play a crucial role in AF, several strategies to prevent or reduce AF have centered around modulating AGP activity directly or indirectly through the extrinsic cardiac nervous system.
PAST AND
PRESENT. C u r r e n t s t r a t e g i e s i n a u t o n o m i c m o d u l a t i o n f o r a t r i a l a r r h y t h m i a s . A number of strategies to reduce AF partially exert their effects through modulation of the cardiac ANS (Table 1) . Beta blockers antagonize the effects of catecholamines on a variety of target tissues, such as cardiac and vascular adrenergic receptors (22) . AF ablation may also exert some benefit through autonomic modulation. In addition to creating electrical isolation of the pulmonary veins from the left atrium Multiple upcoming trials will help elucidate the role of Waldron et al.
Cardiac Neuromodulation
A U G U S T 2 0 1 9 : 5 4 6 -6 2 RDN as a stand-alone technique or in addition to PVI to reduce sympathetically mediated AF ( Table 2) . Abbreviations as in Table 2 . Waldron et al. jonathan.piccini@duke.edu. 
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